跳至主要内容
临床试验/CTRI/2025/10/096244
CTRI/2025/10/096244尚未招募不适用

A Randomized, Open Label, Cross Over, Single Centric Clinical Study to determine the Glycemic Index and Glycemic Response of two different flavors - Shelcal Total Vanilla and Shelcal Total Chocolate Drink in Healthy Indian Adult Participants.

Torrent Pharmaceuticals Ltd.1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年11月21日

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
20
试验地点
1
主要终点
To determine the glycemic index and glycemic response of test products in healthy participants.

研究概览

简要总结

This is a randomized, open label, cross over, single centric clinical study to determine the Glycemic Index and Glycemic Response of two different flavors - Shelcal Total Vanilla and Shelcal Total Chocolate Drink in healthy Indian adult participants.

Each participant will receive 7 treatments consisting of the reference product administered on 3 different occasions and 4 administration of test products (both variants in water for GI and both variants in warm toned milk for GR) as per the randomization schedule.

·       Screening Visit (Within 15 Days)

·       Visit 01: Enrolment Visit and Admission Day (Day 00)

1st Product Administration (Day 01)

·       Visit 02: Admission Day (Day 03)

2nd Product Administration (Day 04)

·       Visit 03: Admission Day (Day 06)

3rd Product Administration (Day 07)

·       Visit 04: Enrolment Visit and Admission Day (Day 09)

4th Product Administration (Day 10)

·       Visit 05: Admission Day (Day 12)

5th Product Administration (Day 13)

·       Visit 06: Admission Day (Day 15)

6th Product Administration (Day 16)

·       Visit 07: Admission Day (Day 18)

                                      7th Product Administration (Day 19)

There will be a washout period of 02 days between doses.

Incremental area under the blood glucose response curve IAUC (0-120 mins), for reference and the test products will be determined for the assessment of glycemic index and glycemic response.

GI/GR score will be calculated using standard formula.

Satiety will be assessed using an equilateral 7-point rating scale at predetermined timepoints

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
All

入选标准

  • Healthy, adult male and non-pregnant/non-lactating female participants between the ages of 18 to 45 years both inclusive at the time of consent.
  • Participants having fasting blood glucose levels less than 100 mg/dL.
  • Participants having HbA1c level less than 5.7 % 4) Participants with Body Mass Index of 18.5 to 22.9 kg/m2 (both inclusive).
  • Participants with good general health as determined by the Investigator based on medical history and vital signs.
  • Participants who are literate and can understand and provide written informed consent to participate in the study.
  • Participants who agree to refrain from vigorous physical exercise during the study period.

排除标准

  • Participants with any known food allergies or intolerance to any food or beverages.
  • Participants who are taking any medication for the past 4 weeks including home remedies for diabetes or ayurvedic medications or any plant extracts.
  • Pre-diabetic participants with HbA1c level of 5.7% to 6.4% and diabetic participants with HbA1c level of 6.5% or higher.
  • Participant with recent history of dehydration from diarrhea, vomiting or any other reason within a period of 24 hours prior to study.
  • Participants who are on an unusual diet, special diet, for whatever reason e.g., high protein diet, low sodium diet, intermittent fasting for two weeks prior to receiving any reference/test product and throughout participant’s participation in the study.
  • Participants who have tested positive for HIV test.
  • Participants with history of Hepatitis B or C virus.

结局指标

主要结局

To determine the glycemic index and glycemic response of test products in healthy participants.

时间窗: 05 mins prior to product administration, 0 min and 15, 30, 45, 60, 90 and 120 minutes post product administration on each product administration day.

次要结局

  • Assessment of Satiety level using an equilateral 7-point rating scale(05 mins prior to product administration and 15, 30, 60, 90 and 120 minutes post product administration on each product administration day.)

研究者

发起方
Torrent Pharmaceuticals Ltd.
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Simran Sethi

Cliantha Research

研究点 (1)

Loading locations...

相似试验